In breast cancer, it is well known that activating mutations in PIK3CA, the gene encoding the catalytic subunit (p110α) of PI3K, occur in almost a quarter of hormone receptor–positive (HR+) breast cancers and approximately 10% of TNBC (24). The gene discussed is NR4A1; the disease is breast carcinoma.